Jamie M. Sperger

2.1k total citations · 1 hit paper
37 papers, 1.3k citations indexed

About

Jamie M. Sperger is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Oncology. According to data from OpenAlex, Jamie M. Sperger has authored 37 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Pulmonary and Respiratory Medicine, 13 papers in Molecular Biology and 12 papers in Oncology. Recurrent topics in Jamie M. Sperger's work include Prostate Cancer Treatment and Research (15 papers), Cancer Genomics and Diagnostics (10 papers) and Radiopharmaceutical Chemistry and Applications (7 papers). Jamie M. Sperger is often cited by papers focused on Prostate Cancer Treatment and Research (15 papers), Cancer Genomics and Diagnostics (10 papers) and Radiopharmaceutical Chemistry and Applications (7 papers). Jamie M. Sperger collaborates with scholars based in United States, Germany and United Kingdom. Jamie M. Sperger's co-authors include Chris H. Chon, James A. Thomson, Jonathan S. Draper, Patrick O. Brown, Peter W. Andrews, James D. Brooks, Xin Chen, Thomas R. Cech, Joshua M. Lang and Karen Chapman and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nucleic Acids Research and Journal of Clinical Oncology.

In The Last Decade

Jamie M. Sperger

33 papers receiving 1.3k citations

Hit Papers

Gene expression patterns in human embryonic stem cells an... 2003 2026 2010 2018 2003 100 200 300 400 500
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Gene expression patterns in human embryonic stem cells and human pluripotent germ cell tumors
    2003 530 citations Jamie M. Sperger et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jamie M. Sperger United States 16 861 271 252 171 170 37 1.3k
Bibhuti Mishra United States 20 1.0k 1.2× 195 0.7× 526 2.1× 128 0.7× 264 1.6× 38 1.6k
Yoshihiro Takemoto Japan 19 503 0.6× 308 1.1× 392 1.6× 70 0.4× 101 0.6× 44 1.2k
Michael J. Gerdes United States 19 616 0.7× 102 0.4× 250 1.0× 56 0.3× 172 1.0× 25 1.0k
Yuxia Cao United States 13 579 0.7× 291 1.1× 239 0.9× 40 0.2× 107 0.6× 25 1.0k
Geeta Upadhyay United States 16 596 0.7× 83 0.3× 266 1.1× 49 0.3× 167 1.0× 31 1.2k
Irina Neganova Russia 16 898 1.0× 84 0.3× 192 0.8× 71 0.4× 139 0.8× 41 1.1k
Tomer‐Meir Salame Israel 15 697 0.8× 103 0.4× 308 1.2× 106 0.6× 188 1.1× 23 1.5k
Corinna Warburton Canada 13 649 0.8× 111 0.4× 155 0.6× 69 0.4× 124 0.7× 16 1.1k
Sirous Zeinali Iran 18 794 0.9× 87 0.3× 142 0.6× 63 0.4× 215 1.3× 112 1.3k
Yaser Atlasi Netherlands 16 1.3k 1.5× 131 0.5× 288 1.1× 42 0.2× 212 1.2× 29 1.5k

Countries citing papers authored by Jamie M. Sperger

Since Specialization
Citations

This map shows the geographic impact of Jamie M. Sperger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jamie M. Sperger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jamie M. Sperger more than expected).

Fields of papers citing papers by Jamie M. Sperger

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jamie M. Sperger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jamie M. Sperger. The network helps show where Jamie M. Sperger may publish in the future.

Co-authorship network of co-authors of Jamie M. Sperger

This figure shows the co-authorship network connecting the top 25 collaborators of Jamie M. Sperger. A scholar is included among the top collaborators of Jamie M. Sperger based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jamie M. Sperger. Jamie M. Sperger is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sperger, Jamie M., Marina N. Sharifi, V. Carreño, et al.. (2024). Abstract 3696: Liquid biopsy biomarker analysis during treatment with 177Lu-PSMA-617 in castrate resistant prostate cancer. Cancer Research. 84(6_Supplement). 3696–3696.
2.
3.
Taylor, Amy K., Jamie M. Sperger, Marina N. Sharifi, et al.. (2023). Association of emergent neuroendocrine prostate cancer detected by liquid biopsies with survival and treatment resistance.. Journal of Clinical Oncology. 41(6_suppl). 247–247. 1 indexed citations
4.
Emamekhoo, Hamid, Petros Grivas, Moshe Chaim Ornstein, et al.. (2023). Prognostic value of integrated liquid biopsies in patients (pts) with metastatic urothelial cancer (mUC).. Journal of Clinical Oncology. 41(6_suppl). 547–547. 1 indexed citations
5.
6.
Héninger, Erika, Shuang G. Zhao, Jamie M. Sperger, et al.. (2022). SEEMLIS: a flexible semi-automated method for enrichment of methylated DNA from low-input samples. Clinical Epigenetics. 14(1). 37–37. 3 indexed citations
7.
McKay, Rana R., Lucia Kwak, Jett Crowdis, et al.. (2021). Phase II Multicenter Study of Enzalutamide in Metastatic Castration-Resistant Prostate Cancer to Identify Mechanisms Driving Resistance. Clinical Cancer Research. 27(13). 3610–3619. 21 indexed citations
8.
Sperger, Jamie M., Susan F. Slovin, Scott T. Tagawa, et al.. (2021). TROP-2 co-expression with androgen receptor splice variants as a new therapeutic target in prostate cancer.. Journal of Clinical Oncology. 39(15_suppl). 5060–5060. 1 indexed citations
9.
Knutson, Todd P., Jamie M. Sperger, Yingming Li, et al.. (2021). AR gene rearrangement analysis in liquid biopsies reveals heterogeneity in lethal prostate cancer. Endocrine Related Cancer. 28(9). 645–655. 4 indexed citations
10.
11.
Huang, Fangjin, Jamie M. Sperger, Joshua M. Lang, et al.. (2018). Regulation of inside-out β1-integrin activation by CDCP1. Oncogene. 37(21). 2817–2836. 13 indexed citations
12.
Ward, Yvona, Ross Lake, Farhoud Faraji, et al.. (2018). Platelets Promote Metastasis via Binding Tumor CD97 Leading to Bidirectional Signaling that Coordinates Transendothelial Migration. Cell Reports. 23(3). 808–822. 117 indexed citations
13.
Sperger, Jamie M., Erika Héninger, Dharmesh Gopalakrishnan, et al.. (2017). Intra-patient heterogeneity in urothelial cancer (UC) circulating tumor cells (CTC) and PDL1 expression to identify biomarkers of response and new therapeutic targets: A pilot study.. Journal of Clinical Oncology. 35(15_suppl). 4537–4537. 5 indexed citations
14.
Warrick, Jay W., David J. Guckenberger, Jamie M. Sperger, et al.. (2017). Interrogating Bronchoalveolar Lavage Samples via Exclusion-Based Analyte Extraction. SLAS TECHNOLOGY. 22(3). 348–357. 1 indexed citations
15.
Lang, Joshua M., Jamie M. Sperger, Scott M. Dehm, et al.. (2017). Trop-2 expression on treatment resistant cancer cells in castrate-resistant prostate cancer (CRPC) as a predictive biomarker for targeted therapy.. Journal of Clinical Oncology. 35(15_suppl). 5045–5045. 1 indexed citations
16.
Sperger, Jamie M., Allison W. Welsh, Benjamin P. Casavant, et al.. (2016). Integrated Analysis of Multiple Biomarkers from Circulating Tumor Cells Enabled by Exclusion-Based Analyte Isolation. Clinical Cancer Research. 23(3). 746–756. 50 indexed citations
17.
Schehr, Jennifer L., Jay W. Warrick, David J. Guckenberger, et al.. (2016). High Specificity in Circulating Tumor Cell Identification Is Required for Accurate Evaluation of Programmed Death-Ligand 1. PLoS ONE. 11(7). e0159397–e0159397. 55 indexed citations
18.
Basu, Hirak S., Jamie M. Sperger, Farideh Mehraein‐Ghomi, et al.. (2015). Abstract 2899: Mitophagy imparts enzalutamide resistance in prostate cancer. Cancer Research. 75(15_Supplement). 2899–2899. 1 indexed citations
19.
Davis, Dawn Belt, Jeremy A. Lavine, Kimberly A. Krautkramer, et al.. (2010). FoxM1 Is Up-Regulated by Obesity and Stimulates β-Cell Proliferation. Molecular Endocrinology. 24(9). 1822–1834. 76 indexed citations
20.
Hanson, Matthew S., et al.. (2009). IL‐1β receptor blockade protects islets against pro‐inflammatory cytokine induced necrosis and apoptosis. Journal of Cellular Physiology. 220(2). 341–347. 48 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Bibhuti Mishra Breakdown of academic impact, for papers by Yoshihiro Takemoto Breakdown of academic impact, for papers by Michael J. Gerdes Breakdown of academic impact, for papers by Yuxia Cao Breakdown of academic impact, for papers by Geeta Upadhyay Breakdown of academic impact, for papers by Irina Neganova Breakdown of academic impact, for papers by Tomer‐Meir Salame Breakdown of academic impact, for papers by Corinna Warburton Breakdown of academic impact, for papers by Sirous Zeinali Breakdown of academic impact, for papers by Yaser Atlasi
Rankless by CCL
2026